SCHEMBL1253141

SCHEMBL1253141

CC(CS(=O)(=O)c1ccc(Cl)cc1)c1nc(-c2cc(C(C)(C)C)nn2C)co1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.39
MAPT P10636 2/20 0.35
MAPK13 O15264 1/20 0.35
MAPK12 P53778 1/20 0.35
MAPK11 Q15759 1/20 0.35
MAPK14 Q16539 1/20 0.35
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
OXTR P30559 1/20 0.32
AVPR1A P37288 1/20 0.32
ATM Q13315 1/20 0.31
ALDH1A1 P00352 2/20 0.31
RORC P51449 1/20 0.31
POLB P06746 2/20 0.31
PRKCZ Q05513 1/20 0.30
LMNA P02545 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1250775 0.92 MEN1 (0.37) CNR2MAPTMAPK14MEN1KMT2A
SCHEMBL1253174 0.90 PHGDH (0.33) KMT2ASMN1; SMN2LMNA
SCHEMBL1250781 0.80 CNR2 (0.39) CNR2MAPTMAPK13MAPK12MAPK11
SCHEMBL1250768 0.78 CNR2 (0.39) CNR2MAPTMAPK13MAPK12MAPK11
SCHEMBL351891 0.76 CNR2 (0.47) CNR2MAPTMAPK13MAPK12MAPK11
SCHEMBL1253138 0.76 CNR2 (0.39) CNR2
SCHEMBL1252448 0.71 AR (0.32) MEN1KMT2AALDH1A1
SCHEMBL1250777 0.70 ALDH1A1 (0.34) CNR2MAPK14MEN1KMT2AALDH1A1
SCHEMBL10147503 0.69 MAPT (0.37) CNR2MAPTMAPK13MAPK12MAPK11
SCHEMBL353288 0.69 CNR2 (0.37) CNR2MAPTMAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2283001-A2 SULFONE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2011-02-16 EP claimed
WO-2009140089-A2 SULFONE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-11-19 WO claimed